start portlet menu bar

Visualizador de conteúdo da Web

Display portlet menu
end portlet menu bar

Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions

Página inicial Conhecimento Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions

Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions

The aim of this study was to confirm the efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) in reducing clinical respiratory signs and the number of concomitant treatments under field conditions.

Transferir este artigo

350 KB

Acerca deste artigo

Data

6 de set de 2016

Sumário

Vaccination with the commercial vaccine HIPRABOVIS® SOMNI/Lkt reduced the number of animals showing clinical respiratory signs and the number of concomitant treatments used during the first three months after arrival at the fattening farm.

Publicações relacionadas

Analysis of the antibodies induced by UBAC® vaccination Vaccinating dry cows and calves: with what, when, and is it effective at protecting the calf? Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions

Partilhar

start portlet menu bar

Vaccination against H. somni and M. haemolytica

Display portlet menu
end portlet menu bar

Consulte também

Publicações

Immune response of dairy cows following vaccination with UBAC® in a clinical trial

13-06-2019
Post

Caso de sucesso: "A vacinação com TOPVAC é uma ferramenta, que vem para somar na luta cont...

04-09-2017
Novidades

HIPRA participates in the VIIIth conference of the Portuguese Council on Udder Health as G...

06-06-2019